Endocrine & recovery

Human randomized studySupporting passage inspected

In a randomized, double-blind, placebo-controlled 14-day trial in 24 resistance-trained men (8 per arm), D-aspartic acid did not increase testosterone: total testosterone fell about 12.5% in the 6 g/day arm (P=.03) and free testosterone fell versus placebo (P=.005), while the 3 g/day arm showed no significant change. An earlier 12-day study in a different, non-resistance-trained population reported increases, so a general testosterone-boosting claim is unsupported.[1][2]

  • Small (n=8 per arm) 14-day trial; results differ from an earlier study in a different population and do not establish recovery after anabolic-androgenic steroid use.
  • Full-text-checked; no qualified clinical review.
Inspection history

Clinical review: not reviewed by a qualified clinician.

· Independent source inspection; applicability narrowed and inherited assertions excluded where unsupported. No qualified clinical review.

· Reopened and read both sources' full open-access PMC text (upgraded from abstract-checked to full-text). Added exact testosterone values, P values and the group sizes; confirmed the earlier study's human groups were not described as randomized. Independent editorial review pending; no qualified clinical review.

Human observational studySupporting passage inspected

An earlier study, whose human groups were not described as randomly assigned, reported that 12 days of oral sodium D-aspartate in 23 men raised serum LH by 33% and testosterone from 4.5 to 6.4 ng/mL (both P<.001), with no change in 20 placebo recipients. A later randomized, double-blind trial in resistance-trained men found no such increase, and a decrease at a higher dose, so this result should not be presented as a reliable effect across populations.[2][1]

  • The human groups were not described as randomly assigned, and separate rat/isolated-pituitary/Leydig-cell mechanistic experiments cannot establish the human mechanism; results conflict with a later randomized trial in resistance-trained men.
  • Full-text-checked; no qualified clinical review.
Inspection history

Clinical review: not reviewed by a qualified clinician.

· Independent source inspection; applicability narrowed and inherited assertions excluded where unsupported. No qualified clinical review.

· Reopened and read both sources' full open-access PMC text (upgraded from abstract-checked to full-text). Confirmed no randomization procedure is described for the human groups and added exact LH/testosterone values. Independent editorial review pending; no qualified clinical review.

What remains unresolved

Editorial assessment

These notes describe the scope of this review. Linked PMIDs are audit identifiers; an identifier alone does not verify a claim.

Narrowly supported passages published with study/product limits; remaining inherited assertions withheld from established-fact displays.

  • Not a comprehensive systematic review. Original monograph topics beyond the individual published claims—including monitoring schedules, contraindication lists, recovery assurances and detailed mechanisms—remain unverified.
  • No qualified clinician has reviewed these claims. Long-term outcomes and all marketed formulations have not been fully assessed.

This reference does not supply a dosing plan, monitoring timetable or recovery regimen. Discuss personal symptoms, medicines and laboratory results with a qualified clinician.

Explore the interaction evidence for this compound →

References

  1. Three and six grams supplementation of d-aspartic acid in resistance trained men.

    Melville GW, Siegler JC, Marshall PW. J Int Soc Sports Nutr. 2015 Apr 6;12:15. doi: 10.1186/s12970-015-0078-7. 2015-04-06. PMID:25844073 · PMCID:PMC4384294 · DOI:10.1186/s12970-015-0078-7 Full text inspected.

    Inspected location: PMC full text (open access): Methods (Subjects, Experimental approach, Statistical analysis); Results (post-treatment testosterone/free testosterone by group, Table 2); Discussion (comparison with Topo et al 2009 and Willoughby & Leutholtz 2013)

    Study context and inspection record
  2. The role and molecular mechanism of D-aspartic acid in the release and synthesis of LH and testosterone in humans and rats.

    Topo E, Soricelli A, D'Aniello A, Ronsini S, D'Aniello G. Reprod Biol Endocrinol. 2009 Oct 27;7:120. doi: 10.1186/1477-7827-7-120. 2009-10-27. PMID:19860889 · PMCID:PMC2774316 · DOI:10.1186/1477-7827-7-120 Full text inspected.

    Inspected location: PMC full text (open access): Methods (human and rat protocols); Results (Effects of D-aspartate on LH and testosterone release in humans, Table 1)

    Study context and inspection record

Source inspection and clinical review are separate. An abstract check is not a full-text review. The records above identify what was actually inspected and do not certify the complete literature.

Recorded verification attempts
  • Fresh PubMed EUtils retrieval for inherited lead PMID 19860889; identity, abstract and linked corrections checked where an abstract existed.
  • https://pubmed.ncbi.nlm.nih.gov/25844073/ — abstract; PubMed abstract: Results: testosterone in two D-aspartic-acid arms versus placebo; Methods: trained men and 14-day exposure
  • https://pubmed.ncbi.nlm.nih.gov/19860889/ — abstract; PubMed abstract: Results: LH/testosterone in treated men; Methods: human sample distinct from rat experiments

View this compound in the research library →

Related records in this class

Grouped under Ancillary compounds for navigation only. Shared class membership does not make findings, formulations or evidence interchangeable between records.

StackItSmart

Age confirmation

This reference discusses steroids, SARMs and other compounds. It is educational, not medical advice, and does not recommend using or combining them.

Your confirmation is saved in this browser when storage is available.